Karen D. Godette

Karen Godette practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Karen Godette's NPI, 1093721029, was assigned on July 31, 2006. Karen Godette graduated from Howard University College Of Medicine in 1988. Karen Godette's Georgia license number on file is 035884.

Karen Godette's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Karen Godette's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. Karen Godette is also affiliated with Emory Saint Joseph's Hospital. The medical group on file is Emory Clinic. Dmand AI also links Karen Godette to 1 more hospital, 1 clinical lab and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Karen Godette practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Karen Godette's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Karen Godette is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Karen Godette's licenses on file in 2 states: Georgia and North Carolina.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, colorectal cancer radiation and prostate cancer radiation among the conditions Karen Godette treats.

CMS data shows 2,515 Medicare services from Karen Godette across 14 procedure codes in 2024, for 177 Medicare patients. Medicare paid $865,321 for them.

CMS counts 177 Medicare patients who saw Karen Godette in 2024. The largest group is 65 to 74, with 103 patients. 75% of them have cancer, and 73% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Karen Godette's median patient age at 70, with 41% women.

In 2024, Karen Godette wrote 118 Medicare Part D claims for 64 patients. 99% of them were for generic drugs. CMS names the drug for 81 of them, across 2 drugs with 11 or more claims each, at $1,005 in total drug cost. In 2023, CMS named 41 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Karen Godette for performance year 2024, reported through an alternative payment model (APM). Karen Godette accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Karen Godette as offering telehealth.

Dmand AI links 34 papers to Karen Godette, published from 2011 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, Brachytherapy and Mastectomy, Segmental. Karen Godette has published most often in Ann Surg Oncol. Karen Godette's most frequent co-authors are Ashesh B. Jani, MD, Vishal Ramesh Dhere, MD and Bruce Warren Hershatter, MD.

Dmand AI links Karen Godette to 1 clinical trial. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 9 general payments to Karen Godette from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Augmenix, Inc. paid the most, $355.

Dmand AI lists 1 award for Karen Godette, most recently Regional Top Doctor in 2014.

Karen Godette graduated from Howard University College Of Medicine in 1988. Karen Godette is a member of ASCO.

Karen Godette is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.